12 research outputs found

    Corrigendum to Bifidobacterium aerophilum sp. nov., Bifidobacterium avesanii sp. nov. and Bifidobacterium ramosum sp. nov.: Three novel taxa from the faeces of cotton-top tamarin (Saguinus oedipus L.)

    No full text
    The authors regret that in the above article in the \u201cDescriptionof Bifidobacterium avesanii sp. nov.\u201d the syllabification is incor-rect. The correct Latin syllabification is a.ve.sa\u2019ni.DSM collection number listed in the section \u201cDescription ofBifidobacterium avesanii sp. nov.\u201d was incorrect. The correct DSMcollection number is 100685T. These changes in no way alter theoriginal conclusions of the pape

    Bifidobacterium aerophilum sp. nov., Bifidobacterium avesanii sp. nov. and Bifidobacterium ramosum sp. nov.: Three novel taxa from the faeces of cotton-top tamarin (Saguinus oedipus L.)

    No full text
    Forty-five microorganisms were isolated on bifidobacteria selective medium from one faecal sample of an adult subject of the cotton-top tamarin (Saguinus oedipus L.). All isolates were Gram-positive, catalase-negative, anaerobic, fructose-6-phosphate phosphoketolase positive, and asporogenous rod-shaped bacteria. In this study, only eight out of the forty-five strains were characterized more deeply, whereas the others are still currently under investigation. They were grouped by BOX-PCR into three clusters: Cluster I (TRE 17T, TRE 7, TRE 26, TRE 32, TRE 33, TRE I), Cluster II (TRE CT), and Cluster III (TRE MT). Comparative analysis of 16S rRNA gene sequences confirmed the results from the cluster analysis and revealed relatively low level similarities to each other (mean value 95%) and to members of the genus Bifidobacterium. All eight isolates showed the highest level of 16S rRNA gene sequence similarities with Bifidobacterium scardovii DSM 13734T (mean value 96.6%). Multilocus sequence analysis (MLSA) of five housekeeping genes (hsp60, rpoB, clpC, dnaJ and dnaG) supported their independent phylogenetic position to each other and to related species of Bifidobacterium. The G + C contents were 63.2%, 65.9% and 63.0% for Cluster I, Cluster II and Cluster III, respectively. Peptidoglycan types were A3\u3b1 l-Lys-l-Thr-l-Ala, A4\u3b2 l-Orn (Lys)-d-Ser-d-Glu and A3\u3b2 l-Orn-l-Ser-l-Ala in Clusters I, II and III, respectively. Based on the data provided, each cluster represented a novel taxon for which the names Bifidobacterium aerophilum sp. nov. (TRE 17T = DSM 100689 = JCM 30941; TRE 26 = DSM 100690 = JCM 30942), Bifidobacterium avesanii sp. nov. (TRE CT = DSM 100685 = JCM 30943) and Bifidobacterium ramosum sp. nov. (TRE M = DSM 100688 = JCM 30944) are proposed

    Bifidobacterium. eulemuris sp. nov. isolated from the faeces of the black lemur (Eulemur macaco)

    No full text
    Forty strains of bifidobacteria were isolated from the faeces of two adult subjects of black lemur, Eulemur macaco. Twenty-five were identified as Bifidobacterium lemurum, the novel species recently described in Lemur catta. All other isolates resulted Gram-positive-staining, non-spore-forming, fructose-6-phosphate phosphoketolase positive, microaerophilic, irregular rod-shaped bacteria that often resembled Y or V shapes cells. Typing techniques revealed these isolates were nearly identical and strain LMM_E3T was chosen as representative and characterized further. Phylogenetic analysis based on 16S rRNA gene sequences clustered this isolate inside the genus Bifidobacterium and showed the highest levels of sequence similarities with Bifidobacterium lemurum DSM 28807T (99.6%), with Bifidobacterium pullorum LMG 21816T and Bifidobacterium longum subsp. infantis ATCC 15697T (96.4 % and 96.3%, respectively). Analysis of hsp60 gene sequences revealed that strain LMM_E3T was also closely related to Bifidobacterium stellenboschense DSM 23968T (93.3%). DNA-DNA reassociation value with the closest neighbour B. lemurum DSM 28807T was found to be 65.4%. The DNA base composition was 62.3 mol% G+C. Strain LMM_E3T showed a peptidoglycan structure which has not been detected in bifidobacteria so far: A3\u3b1 L-Lys - L-Ser - L-Thr - L-Ala. Based on the phylogenetic, genotypic and phenotypic data, strain LMM_E3 T represents a novel species within the genus Bifidobacterium for which the name Bifidobacterium eulemuris sp. nov. is now proposed; the type strain is LMM_E3T (=DSM 100216T; = JCM 30801T)

    Oli essenziali in patologia vegetale: potenziale mezzo per la difesa dai batteri fitopatogeni

    No full text
    Ad oggi le batteriosi delle piante sono gestite mediante strategie integrate di lotta chimica (metalli pesanti ed induttori di resistenza) e biologica (microrganismi antagonisti). Gli oli essenziali (OE) sono miscele complesse di composti altamente volatili, ottenute per distillazione in corrente di vapore di piante officinali e manifestanti spesso attività antimicrobica; il sottoprodotto di questo processo è l’idrolato, che contiene molecole bioattive idrosolubili a basse concentrazioni (< 0,1%) (Di Vito et al., 2019). In questo studio è stata valutata l’attività antibatterica in vitro di diversi OE ed idrolati nei confronti di differenti specie batteriche fitopatogene. Alcuni OE ed idrolati selezionati sono stati saggiati in vivo contro Erwinia amylovora (Ea).Le prove in vitro hanno rilevato un’attività battericida degli OE e degli idrolati testati anche a basse concentrazioni, tuttavia le prove in vivo non hanno confermato questi risultati. Verosimilmente l’inefficacia di OE/idrolati in vivo potrebbe essere dovuta alla modalità di somministrazione. Per saggiare questa ipotesi sarà necessario eseguire ulteriori indagini usando diverse formulazioni/emulsioni degli antimicrobici naturali considerati

    Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?

    No full text
    The diagnostic performance of isolated high-grade prostatic intraepithelial neoplasia in prostatic biopsies has recently been questioned, and molecular analysis of high-grade prostatic intraepithelial neoplasia has been proposed for improved prediction of prostate cancer. Here, we retrospectively studied the value of isolated high-grade prostatic intraepithelial neoplasia and the immunohistochemical markers ?-methylacyl coenzyme A racemase, Bcl-2, annexin II, and Ki-67 for better risk stratification of high-grade prostatic intraepithelial neoplasia in our local Swiss population. From an initial 165 diagnoses of isolated high-grade prostatic intraepithelial neoplasia, we refuted 61 (37%) after consensus expert review. We used 30 reviewed high-grade prostatic intraepithelial neoplasia cases with simultaneous biopsy prostate cancer as positive controls. Rebiopsies were performed in 66 patients with isolated high-grade prostatic intraepithelial neoplasia, and the median time interval between initial and repeat biopsy was 3 months. Twenty (30%) of the rebiopsies were positive for prostate cancer, and 10 (15%) showed persistent isolated high-grade prostatic intraepithelial neoplasia. Another 2 (3%) of the 66 patients were diagnosed with prostate cancer in a second rebiopsy. Mean prostate-specific antigen serum levels did not significantly differ between the 22 patients with prostate cancer and the 44 without prostate cancer in rebiopsies, and the 30 positive control patients, respectively (median values, 8.1, 7.7, and 8.8 ng/mL). None of the immunohistochemical markers, including ?-methylacyl coenzyme A racemase, Bcl-2, annexin II, and Ki-67, revealed a statistically significant association with the risk of prostate cancer in repeat biopsies. Taken together, the 33% risk of being diagnosed with prostate cancer after a diagnosis of high-grade prostatic intraepithelial neoplasia justifies rebiopsy, at least in our not systematically prostate-specific antigen-screened population. There is not enough evidence that immunohistochemical markers can reproducibly stratify the risk of prostate cancer after a diagnosis of isolated high-grade prostatic intraepithelial neoplasia

    Essential Oils and Hydrolates: Potential Tools for Defense against Bacterial Plant Pathogens

    No full text
    The essential oils (EOs) of Origanum compactum and Satureja montana chemotyped (CT) at carvacrol, two Thymus vulgaris CT at thujanol and thymol, and Hydrolates (Hys) of S. montana and Citrus aurantium var. amara were chosen for studying their bactericidal efficacy against few phytobacterial pathogens. The Minimal Inhibitory Concentration (MIC) and Bactericidal Concentration (MBC) were found by microdilution assay. The essential oils of O. compactum (MBC 0.06% v/v), T. vulgaris CT thymol (MBC 0.06% v/v), and Hy of C. aurantium (MBC 6.25% v/v) resulted in being the most effective against Erwinia amylovora; thus, they were used as starting concentrations for ex vivo assays. Despite the great in vitro effectiveness, the disease incidence and the population dynamic ex vivo assays showed no significant results. On the other hand, EO of O. compactum and Hy of C. aurantium (at 0.03% and 4.5% v/v, respectively) showed resistance induction in tomato plants against Xanthomonas vesicatoria infections; both treatments resulted in approximately 50% protection. In conclusion, EOs and Hys could be promising tools for agricultural defense, but further studies will be necessary to stabilize the EOs emulsions, while Hys application could be an effective method to prevent bacterial diseases when used as resistance inducer by pre-transplantation treatment at roots

    Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

    No full text
    Accurate prognostic parameters in prostate biopsies are needed to better counsel individual patients with prostate cancer. We evaluated the prognostic impact of morphologic and immunohistochemical parameters in preoperative prostate cancer biopsies. A consecutive series of prostate biopsies of 279 men (72% with clinical stage T1c and 23% with T2) who subsequently underwent radical prostatectomy was prospectively analysed for Gleason score, number and percentage of positive cores (NPC, PPC), total percentage of biopsy tissue with tumour (TPT), maximum tumour percentage per core (MTP), and expression of Ki67, Bcl-2 and p53. All biopsy features were significantly associated with at least one feature of the radical prostatectomy specimen. pT stage was independently predicted by PSA, seminal vesicle invasion by Ki67 LI, positive margins by PSA and MTP, large tumour diameter by PSA and PPC, and Gleason score by biopsy Gleason score, MTP, and Ki67 LI, respectively. Biopsy Gleason score, NPC (1 vs. 7 vs. 10 vs. 0.01, each). KI67 LI was the only independent prognostic factor in case of a low TPT (>7%) or low Gleason score (>7), the hazard ratio being 6.76 and 6.44, respectively. In summary, preoperative Gleason score, NPC, TPT and Ki67 LI significantly predict the risk of recurrence after radical prostatectomy, and Ki67 is an independent prognosticator in biopsies with low-volume or low-grade prostate cancer. Analysis of Ki67 LI in these biopsies may help to better identify patients with clinically insignificant prostate cancer
    corecore